|
1. Pfizer inks $2B deal for early-stage GLP-1 Full story
2. FDA expands COVID vaccine death review to include adults Full story
3. New data: How value analysis and pharmacy leaders evaluate products now. Results here.
4. Blood pressure medication recalled: What to know Full story
5. GLP-1s may not affect obesity-related cancer risk: Study Full story
6. How will healthcare's new power brokers reshape care delivery in 2026? Get answers here.
7. Trump orders review of international immunization schedules: 3 federal vaccine updates Full story
8. FDA names acting head of drug evaluation center Full story
Becker's Learning Opportunities
9. Workforce shortages are accelerating. Mount Sinai + others reveal new entry points improving clinician well-being here.
10. 13 hospitals, 1 strategy: How MultiCare grew staffed OR utilization 25% here.
11. Hospitals are linking safety and retention for real impact: 62% fewer incidents, stronger trust here.
12. Becker’s resources don’t stop here — explore more
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
